Endocrinology, Vol 128, 3175-3182, Copyright © 1991 by Endocrine Society

ARTICLES

Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides

PL Brubaker
Department of Physiology, University of Toronto, Ontario, Canada.

The physiological regulation of intestinal proglucagon-derived peptide secretion has not been well studied. We have therefore used a fetal rat intestinal cell culture model to investigate the control of secretion of the gut glucagon-like immunoreactive (GLI) peptides by other intestinal regulatory peptides in vitro. Secretion of the intestinal GLI peptides was found to be stimulated in a dose-dependent fashion by the intestinal endocrine peptide, gastric inhibitory peptide (at greater than or equal to 10(-10) M, P less than 0.05), and by the neurocrine peptides, gastrin-releasing peptide (at greater than or equal to 10(-12) M, P less than 0.05), and calcitonin gene-related peptide (at greater than or equal to 10(-8) M, P less than 0.05). Gastrin-releasing peptide and its amphibian equivalent, bombesin were equipotent in stimulating GLI peptide secretion. In contrast, the endocrine and neurocrine intestinal somatostatin-related peptides, somatostatin-28 and -14, inhibited release of the GLI peptides, at concentrations of 10(-10) (P less than 0.01) and 10(-8) (P less than 0.01) M, respectively, with significant differences in potency between the two peptides detected at 10(-10) M (P less than 0.05). The inhibitory effects of both somatostatin-28 and -14 could be blocked by preincubation of the cells with pertussis toxin (P less than 0.05). Dose-dependent stimulation of gut GLI peptide secretion was also detected in response to treatment of cultured cells with sodium oleate (at 10(-4) M; P less than 0.05), or with the cholinergic agonist bethanecol (at greater than or equal to 100 microM; P less than 0.05). Other endocrine [cholecystokinin, glucagon, glucagon-like peptide-1(1- 37), glucagon-like peptide-1(7-37), glucagon-like peptide-2, neurotensin, and peptide YY] and neurocrine (vasoactive intestinal peptide) peptides, and the synthetic glucocorticoid, dexamethasone, were without effect on secretion of the gut GLI peptides, at doses of 10(-12) to 10(-6) M. The results of the present study therefore demonstrate that secretion of the intestinal proglucagon-derived peptides is under the regulatory control of a wide variety of intestinal endocrine and neurocrine peptides, as well as nutrients (fats) and neurotransmitters (acetylcholine).

This article has been cited by other articles:

				Z.-L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, D. Bagnol, et al. A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release Endocrinology, May 1, 2008; 149(5): 2038 - 2047. [Abstract] [Full Text] [PDF]

				R. Iakoubov, A. Izzo, A. Yeung, C. I. Whiteside, and P. L. Brubaker Protein Kinase C{zeta} Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells Endocrinology, March 1, 2007; 148(3): 1089 - 1098. [Abstract] [Full Text] [PDF]

				G. E. Lim and P. L. Brubaker Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77. [Abstract] [Full Text] [PDF]

				L. Hansen, S. Lampert, H. Mineo, and J. J. Holst Neural regulation of glucagon-like peptide-1 secretion in pigs Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947. [Abstract] [Full Text] [PDF]

				Y. Anini and P. L. Brubaker Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells Endocrinology, July 1, 2003; 144(7): 3244 - 3250. [Abstract] [Full Text] [PDF]

				S. Y. Wang, M. M.-Y. Chi, L. Li, K. H. Moley, and B. M. Wice Studies with GIP/Ins cells indicate secretion by gut K cells is KATP channel independent Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E988 - E1000. [Abstract] [Full Text] [PDF]

				Y. Anini and P. L. Brubaker Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion Diabetes, February 1, 2003; 52(2): 252 - 259. [Abstract] [Full Text] [PDF]

				Y. Anini, T. Hansotia, and P. L. Brubaker Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats Endocrinology, June 1, 2002; 143(6): 2420 - 2426. [Abstract] [Full Text] [PDF]

				R. A. Reimer, C. Darimont, S. Gremlich, V. Nicolas-Metral, U. T. Ruegg, and K. Mace A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion Endocrinology, October 1, 2001; 142(10): 4522 - 4528. [Abstract] [Full Text] [PDF]

				A. S. Rocca, J. LaGreca, J. Kalitsky, and P. L. Brubaker Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1 Endocrinology, March 1, 2001; 142(3): 1148 - 1155. [Abstract] [Full Text] [PDF]

				K. Persson, R. L. Gingerich, S. Nayak, K. Wada, E. Wada, and B. Ahren Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E956 - E962. [Abstract] [Full Text] [PDF]

				L. Hansen, B. Hartmann, T. Bisgaard, H. Mineo, P. N. Jorgensen, and J. J. Holst Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1010 - E1018. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				C.-C. Tseng, X.-Y. Zhang, and M. M. Wolfe Effect of GIP and GLP-1 antagonists on insulin release in the rat Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1049 - E1054. [Abstract] [Full Text] [PDF]

				A. S. Rocca and P. L. Brubaker Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion Endocrinology, April 1, 1999; 140(4): 1687 - 1694. [Abstract] [Full Text]

				P. L. Brubaker, J. Schloos, and D. J. Drucker Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line Endocrinology, October 1, 1998; 139(10): 4108 - 4114. [Abstract] [Full Text] [PDF]

				A. B. Damholt, A. M. J. Buchan, and H. Kofod Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose Endocrinology, April 1, 1998; 139(4): 2085 - 2091. [Abstract] [Full Text] [PDF]

				P. L. Brubaker, K. A. Gronau, S. L. Asa, and G. R. Greenberg Nutrient and Peptide Regulation of Somatostatin-28 Secretion from Intestinal Cultures Endocrinology, January 1, 1998; 139(1): 148 - 155. [Abstract] [Full Text] [PDF]

				H. J. Balks, J. J. Holst, A. von zur Muhlen, and G. Brabant Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic Receptors J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 786 - 790. [Abstract] [Full Text] [PDF]